البحث عن طبيب

James W. Jakub, M.D.

  1. General Surgeon
  2. Surgical Oncologist
طلب موعد

المنشورات

  1. Sonam F, Komforti MK, Jakub JW, Cornell LF, Robinson KA. Rare Presentation of Papillary Carcinoma Within a Sentinel Lymph Node in a Patient With Ductal Carcinoma in Situ of the Breast: A Challenging but Useful Case Report Discussion Regarding Displacement or True Metastasis? Int J Surg Pathol. 2024 Dec; 32 (8):1588-1594 Epub 2024 Mar 18
    View PubMed
  2. Jakub JW, Boughey JC, Hieken TJ, Piltin M, Forte AJ, Vijayasekaran A, Mazur M, Sturz J, Corbin K, Vallow L, Johnson JE, Mrdutt M, Fahradyan V, Li Z, Blumenfeld S, Degnim A, Yost KJ, Cheville A, McLaughlin SA. Lymphedema Rates Following Axillary Lymph Node Dissection With and Without Immediate Lymphatic Reconstruction: A Prospective Trial. Ann Surg Oncol. 2024 Oct; 31 (11):7349-7359 Epub 2024 July 02
    View PubMed
  3. Mutter RW, Golafshar MA, Buras MR, Comstock BP, Jacobson M, DeWees T, Remmes NB, Francis LN, Boughey JC, Ruddy KJ, McGee LA, Afzal A, Vallow LA, Furutani KM, Deufel CL, Shumway DA, Kim H, Liu MC, Degnim AC, Jakub JW, Vern-Gross TZ, Wong WW, Patel SH, Vargas CE, Stish BJ, Waddle MR, Pafundi DH, Halyard MY, Corbin KS, Hieken TJ, Park SS. Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial. Int J Radiat Oncol Biol Phys. 2024 Sep 17 Epub 2024 Sept 17
    View PubMed
  4. Rosenberger LH, Thomas SM, Hieken TJ, Gallagher KK, Spanheimer PM, Neuman HB, Weiss AC, King TA, Wong J, Tong BS, Nash AL, Frazier MP, Menendez CS, Hwang ES, Jakub JW, Plichta JK. Germline genetic mutations in a multi-center cohort of 248 phyllodes tumors. Breast Cancer Res Treat. 2024 Sep 13 Epub 2024 Sept 13
    View PubMed
  5. Hatcher KM, Leon A, Cornell LF, Jakub JW, McLaughlin SA, Maimone S. Evaluating acute nipple inversion, imaging findings and outcomes. Clin Imaging. 2024 Sep; 113:110242 Epub 2024 July 29
    View PubMed
  6. Merrell KW, Konney TO, Acheamfour O, Lucido J, Aduse-Poku AY, Kumar A, Ansah MB, Amankwa AT, Shumway D, Awittor FK, Badu-Peprah A, Fonkoua LAAK, Hendrickson AEW, Boakye E, Adjei EK, Kyei I, Kemper K, Rank M, Peethambaram PP, Spangenberg K, Sorenson K, Hearrold M, Garda A, Graham R, Lang K, Adom J, Achiaa R, Jakub J, Amo BD, Osei-Bonsu E, Camacho R, Addison ECDK. Participant Evaluation of a Multi-disciplinary Oncology Preceptorship Training Program for Oncology Health Professionals from Kumasi, Ghana. J Cancer Educ. 2024 Aug; 39(4):360-367. Epub 2024 Mar 20.
    View PubMed
  7. Suman S, Nevala WK, Leontovich AA, Ward C, Jakub JW, Kim Y, Geng L, Stueven NA, Atherton CL, Moore RM, Schimke JM, Lucien-Matteoni F, McLaughlin SA, Markovic SN. Melanoma-Derived Extracellular Vesicles Induce CD36-Mediated Pre-Metastatic Niche. Biomolecules. 2024 Jul 11; 14 (7) Epub 2024 July 11
    View PubMed
  8. Lee CU, Urban MW, Hesley GK, Wood BG, Meier TR, Chen B, Kassmeyer BA, Larson NB, Lee Miller A 2nd, Herrick JL, Jakub JW, Piltin MA. Long-Term Ultrasound Twinkling Detectability and Safety of a Polymethyl Methacrylate Soft Tissue Marker Compared to Conventional Breast Biopsy Markers-A Preclinical Study in a Porcine Model. Ultrasound Med Biol. 2024 Jul; 50 (7):1001-1009 Epub 2024 Apr 04
    View PubMed
  9. Jakub JW, Advani P, Maxwell R, Vallow L, Maimone S, McLaughlin S. SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We Ready to Change the Tune of Our Breast Cancer Practice? Ann Surg Oncol 2024 Jun; 31 (6):3672-3674 Epub 2024 Feb 28
    View PubMed
  10. Van Decar SG, Carpenter EL, Adams AM, Chick RC, Clifton GT, Stojadinovic A, Vreeland TJ, Valdera FA, Tiwari A, O'Shea AE, McCarthy PM, Hale DF, Bohan PMK, Hickerson AT, Cindass JL, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Yu X, Wagner T, Faries MB, Peoples GE. Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial. Cancer Treat Res Commun. 2024; 41:100843 Epub 2024 Sept 11
    View PubMed
  11. Huang K, Jakub JW, McLaughlin SA. ASO Author Reflections: Sequence of Treatment in Clinically Node-Negative T1 Triple-Negative Breast Cancer. Ann Surg Oncol. 2023 Dec; 30 (13):8455-8456 Epub 2023 Aug 11
    View PubMed
  12. Sarcon AK, Zhang W, Degnim AC, Johnson RL, Harmsen WS, Glasgow AE, Jakub JW. The Benefits of Local Anesthesia Used in Mastectomy Without Reconstruction. Am Surg. 2023 Nov; 89 (11):4271-4280 Epub 2022 June 03
    View PubMed
  13. Huang K, Jakub J, Gabriel E, Moreno-Aspitia A, McLaughlin S. ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer. Ann Surg Oncol. 2023 Nov; 30 (12):7143
    View PubMed
  14. Huang K, Jakub J, Gabriel E, Moreno-Aspitia A, McLaughlin S. Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer. Ann Surg Oncol. 2023 Nov; 30 (12):7026-7035 Epub 2023 July 25
    View PubMed
  15. Benolken MM, Jakub JW. ASO Author Reflections: Axillary Reverse Mapping: Where Do We Go from Here? Ann Surg Oncol 2023 Oct; 30 (10):6051-6052 Epub 2023 July 21
    View PubMed
  16. Benolken MM, McLaughlin S, Piltin M, Mrdutt M, Li Z, Jakub JW. ASO Visual Abstract: Lymph Node Positivity of Axillary Reverse Mapping Lymph Nodes at Time of Axillary Lymph Node Dissection, 2 Site Prospective Trial. Ann Surg Oncol. 2023 Oct; 30 (10):6050
    View PubMed
  17. Carpenter EL, Van Decar S, Adams AM, O'Shea AE, McCarthy P, Chick RC, Clifton GT, Vreeland T, Valdera FA, Tiwari A, Hale D, Kemp Bohan P, Hickerson A, Smolinsky T, Thomas K, Cindass J, Hyngstrom J, Berger AC, Jakub J, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries M, Peoples GE. Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis. J Immunother Cancer. 2023 Aug; 11 (8)
    View PubMed
  18. Degnim AC, Siontis BL, Ahmed SK, Hoskin TL, Hieken TJ, Jakub JW, Baum CL, Day C, Schrup SE, Smith L, Carter JM, Sae-Kho TM, Sae Kho TM, Glazebrook KN, Vijayasekaran A, Okuno SH, Petersen IA. Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast. Clin Cancer Res. 2023 Aug 1; 29 (15):2885-2893
    View PubMed
  19. Mohan AT, MacArthur TA, Murphy B, Song AJ, Saifuddin H, Degnim A, Harmsen WS, Martinez-Jorge J, Jakub JW, Vijayasekaran A. Patient Experience and Clinical Outcomes after Same-day Outpatient Mastectomy and Immediate Breast Reconstruction Protocol during the Global Pandemic. Plast Reconstr Surg Glob Open. 2023 Jul; 11 (7):e5183 Epub 2023 July 24
    View PubMed
  20. Kim H, Hieken TJ, Abraha F, Jakub JW, Corbin KS, Furutani KM, Boughey JC, Stish BJ, Deufel CL, Degnim AC, Shumway DA, Ahmed SK, Piltin MA, Sandhu NP, Conners AL, Ruddy KJ, Mutter RW, Park SS. Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data. Clin Transl Radiat Oncol. 2023 Jul; 41:100639 Epub 2023 May 09
    View PubMed
  21. Saifuddin H, Yan M, Jakub J, Martinez-Jorge J, Roenigk R, Vijayasekaran A. Wide local excision, Mohs micrographic surgery, and reconstructive options for treatment of dermatofibrosarcoma protuberans of the breast: A retrospective case series from Mayo Clinic. World J Surg Oncol. 2023 May 6; 21 (1):141 Epub 2023 May 06
    View PubMed
  22. Nash AL, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Hwang ES, Jakub JW, Rosenberger LH. Racial-ethnic variations in phyllodes tumors among a multicenter United States cohort. J Surg Oncol. 2023 Mar; 127 (3):369-373 Epub 2022 Oct 07
    View PubMed
  23. Lee CU, Larson NB, Urban MW, Miller AL 2nd, Uthamaraj S, Piltin MA, Jakub JW, Bhatt AA, Greenleaf JF, Hesley GK. Factors Associated With Ultrasound Color Doppler Twinkling by Breast Biopsy Markers: In Vitro and Ex Vivo Evaluation of 35 Commercially Available Markers. AJR Am J Roentgenol. 2023 Mar; 220 (3):358-370 Epub 2022 Aug 31
    View PubMed
  24. Adams AM, Carpenter EL, Clifton GT, Vreeland TJ, Chick RC, O'Shea AE, McCarthy PM, Kemp Bohan PM, Hickerson AT, Valdera FA, Tiwari A, Hale DF, Hyngstrom JR, Berger AC, Jakub JW, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries MB, Peoples GE. Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial. Cancer Immunol Immunother. 2023 Mar; 72 (3):697-705 Epub 2022 Sept 01
    View PubMed
  25. Bangalore Kumar A, Peters MS, Jakub JW, Harmsen W, Baum CL. Primary cutaneous melanoma features predict development of in-transit metastases/satellite lesions: Mayo Clinic experience, 2010 to 2014. J Am Acad Dermatol. 2023 Feb; 88(2):455-457. Epub 2022 Jun 13.
    View PubMed
  26. Jakub JW, Zhang W, Solanki M, Yonkus J, Boughey JC, Harmsen S, Giridhar KV. Response Rates of Invasive Lobular Cancer in Patients Undergoing Neoadjuvant Endocrine or Chemotherapy. Am Surg. 2023 Feb; 89 (2):230-237 Epub 2022 Oct 27
    View PubMed
  27. Durgan DM, De La Cruz Ku G, Thomas M, Pockaj BA, McLaughlin SA, Casey WJ, Vijayasekaran A, Wigle D, Cheville JC, Tonneson J, Hoskin TL, Jakub JW. Chest wall resection for breast cancer: 21st century Mayo clinic experience. J Surg Oncol. 2022 Nov; 126 (6):962-969 Epub 2022 July 13
    View PubMed
  28. Broida SE, Chen XT, Baum CL, Brewer JD, Block MS, Jakub JW, Pockaj BA, Foote RL, Markovic SN, Hieken TJ, Houdek MT. Merkel cell carcinoma of unknown primary: Clinical presentation and outcomes. J Surg Oncol. 2022 Nov; 126 (6):1080-1086 Epub 2022 July 09
    View PubMed
  29. Jakub JW, Hesley GK, Larson NB, Yaszemski MJ, Lee Miller A 2nd, Greenleaf JF, Urban MW, Lee CU. Ultrasonographic Detection and Surgical Retrieval of a Nonmetallic Twinkle Marker in Breast Cancer: Pilot Study. Radiol Imaging Cancer. 2022 Nov; 4 (6):e220053
    View PubMed
  30. Robbins T, Hoskin TL, Day CN, Mrdutt MM, Hieken TJ, Jakub JW, Glazebrook K, Boughey JC, Degnim AC. Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes. Ann Surg Oncol. 2022 Oct; 29 (10):6276-6287 Epub 2022 July 19
    View PubMed
  31. Manrique OJ, Bustos SS, Ciudad P, Adabi K, Chen WF, Forte AJ, Cheville AL, Jakub JW, McLaughlin SA, Chen HC. Overview of Lymphedema for Physicians and Other Clinicians: A Review of Fundamental Concepts. Mayo Clin Proc. 2022 Oct; 97(10):1920-1935. Epub 2020 Aug 20.
    View PubMed
  32. Jakub JW, Weaver AL, Meves A. Association of tumor molecular factors with in-transit metastasis in primary cutaneous melanoma. Int J Dermatol. 2022 Sep; 61 (9):1117-1123 Epub 2022 Mar 05
    View PubMed
  33. Jakub JW, Faries MB. ASO Author Reflections: Minimally Invasive Inguinal Lymphadenectomy, an Incremental Step in the Evolution of the Management of Advanced Melanoma. Ann Surg Oncol 2022 Sep; 29 (9):5921-5922 Epub 2022 Apr 30
    View PubMed
  34. Jakub JW, Lowe M, Howard JH, Farma JM, Sarnaik A, Tuttle T, Neuman HB, Ariyan CE, Uppal A, Trocha S, Beasley GM, Wasif N, Bilimoria KY, Thomay AA, Allred JB, Chen L, Terando AM, Wayne JD, Thompson JF, Cochran AJ, Sim MS, Elashoff DE, Delman KA, Faries MB. Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II). Ann Surg Oncol. 2022 Sep; 29 (9):5910-5920 Epub 2022 May 02
    View PubMed
  35. Lee CU, Urban MW, Lee Miller A 2nd, Uthamaraj S, Jakub JW, Hesley GK, Wood BG, Brinkman NJ, Herrick JL, Larson NB, Yaszemski MJ, Greenleaf JF. Twinkling-guided ultrasound detection of polymethyl methacrylate as a potential breast biopsy marker: a comparative investigation. Eur Radiol Exp. 2022 Jun 17; 6 (1):26 Epub 2022 June 17
    View PubMed
  36. Shukla SS, Bhatt AA, Jakub JW, Solanki MH, Kaur AS, Liu MC, Corbin KS, Axmacher JA. Local Recurrence of Invasive Secretory Breast Carcinoma in a Gravid Patient Post-Mastectomy. Radiol Case Rep. 2022 Jun; 17 (6):1901-1904 Epub 2022 Apr 05
    View PubMed
  37. Jakub JW, Lowe M, Harrison Howard J, Farma JM, Sarnaik A, Tuttle T, Neuman HB, Ariyan CE, Uppal A, Trocha S, Beasley GM, Wasif N, Bilimoria KY, Thomay AA, Allred JB, Chen L, Terando AM, Wayne JD, Thompson JF, Cochran AJ, Sim MS, Elashoff DE, Delman KA, Faries MB. ASO Visual Abstract: Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in MSLT-II. Ann Surg Oncol. 2022 May 12 [Epub ahead of print]
    View PubMed
  38. Abd El Aziz MA, McKenna NP, Jakub JW, Hallemeier CL, Kelley SR, Jin Z, Mathis KL. Rectal cancer with synchronous inguinal lymph node metastasis without distant metastasis. A call for further oncological evaluation. Eur J Surg Oncol. 2022 May; 48 (5):1100-1103 Epub 2021 Dec 20
    View PubMed
  39. Szabo Yamashita T, Yeh VJH, Lund S, Rivera M, McKenzie TJ, Stulak JM, Heller SF, Jakub JW. The Lake Wobegon effect is real: All general surgery residents appear to be better than average. Surgery in Practice and Science. 2022; 11:100134
  40. Asaad M, Yonkus JA, Hoskin TL, Hieken TJ, Jakub JW, Boughey JC, Degnim AC. Primary tumor resection in patients with stage IV breast cancer: 10-year experience. Breast J. 2021 Dec; 27 (12):863-871 Epub 2021 Oct 14
    View PubMed
  41. Rosenberger LH, Quintana LM, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW, Bentley RC, Schnitt SJ. ASO Visual Abstract: Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization. Ann Surg Oncol 2021 Dec; 28 (Suppl 3):465-466
    View PubMed
  42. Rosenberger LH, Quintana LM, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW, Bentley RC, Schnitt SJ. Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization. Ann Surg Oncol. 2021 Nov; 28 (12):7404-7409 Epub 2021 May 14
    View PubMed
  43. Vreeland TJ, Clifton GT, Hale DF, Chick RC, Hickerson AT, Cindass JL, Adams AM, Bohan PMK, Andtbacka RHI, Berger AC, Jakub JW, Sussman JJ, Terando AM, Wagner T, Peoples GE, Faries MB. A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis. Ann Surg Oncol. 2021 Oct; 28 (11):6126-6137 Epub 2021 Feb 27
    View PubMed
  44. Guru SD, Hoskin TL, Whaley DH, Nathan MA, Jakub JW. Repeat Sentinel Lymph Node Surgery in Recurrent Breast Cancer: Peritumoral vs. Periareolar Injections. Clin Breast Cancer. 2021 Oct; 21 (5):466-476 Epub 2021 Feb 18
    View PubMed
  45. Naranjo J, Portner ER, Jakub JW, Cheville AL, Nuttall GA. Ipsilateral Intravenous Catheter Placement in Breast Cancer Surgery Patients. Anesth Analg. 2021 Sep 1; 133 (3):707-712
    View PubMed
  46. Adams AM, Chick RC, Vreeland TJ, Clifton GT, Hale DF, McCarthy PM, O'Shea AE, Bohan PMK, Hickerson AT, Park H, Sloan AJ, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Wagner T, Faries MB, Peoples GE. Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma. Melanoma Res. 2021 Aug 1; 31 (4):378-388
    View PubMed
  47. Gorman BG, Jakub JW, Hobday TJ, Brewer JD. Intratumoral Interleukin-2 Injections Without Systemic Therapy for Isolated Cutaneous Metastatic Breast Cancer. Dermatol Surg. 2021 Aug 1; 47 (8):1119-1121
    View PubMed
  48. Chick RC, Faries MB, Hale DF, Kemp Bohan PM, Hickerson AT, Vreeland TJ, Myers JW 3rd, Cindass JL, Brown TA 2nd, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Clifton GT, Park H, Sloan AJ, Wagner T, Peoples GE. Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis. Cancer Med. 2021 Jul; 10 (13):4302-4311 Epub 2021 May 12
    View PubMed
  49. Adams AM, Chick RC, Vreeland TJ, Clifton GT, Hale DF, McCarthy PM, O'Shea AE, Bohan PMK, Hickerson AT, Park H, Sloan AJ, Hyngstrom J, Berger AC, Jakub JW, Sussman JJ, Shaheen M, Wagner T, Faries MB, Peoples GE. Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma. Melanoma Res. 2021 Jun 29 Epub 2021 June 29
    View PubMed
  50. MacArthur TA, Fahy AS, Jakub JW. Surgical Resection After Talimogene Laherparepvec for Melanoma: Persistent Fuorodeoxyglucose Avidity on Positron Emission Tomography Despite No Viable Disease. Am Surg. 2021 Jun; 87 (6):849-854 Epub 2021 June 01
    View PubMed
  51. Yonkus JA, Jakub JW. Anterior Axillary Arch: An Anatomic Variant Every Surgeon Operating in the Axilla Should Be Aware of. J Surg Res. 2021 Mar; 259:170-174 Epub 2020 Dec 04
    View PubMed
  52. Murphy BL, Jakub JW, Asaad M, Day CN, Hoskin TL, Habermann EB, Boughey JC. Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients: When to Stop? Ann Surg Oncol. 2021 Feb; 28 (2):888-893 Epub 2020 Aug 20
    View PubMed
  53. Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW. Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines. J Clin Oncol. 2021 Jan 20; 39 (3):178-189 Epub 2020 Dec 10
    View PubMed
  54. Jurgens A, Guru S, Guo R, Brewer J, Bridges A, Jakub J, Comfere N. Tumoral Melanosis in the Setting of Targeted Immunotherapy for Metastatic Melanoma-A Single Institutional Experience and Literature Review. Am J Dermatopathol. 2021 Jan 1; 43 (1):9-14
    View PubMed
  55. Racz JM, Glasgow AE, Keeney GL, Degnim AC, Hieken TJ, Jakub JW, Cheville JC, Habermann EB, Boughey JC. Intraoperative Pathologic Margin Analysis and Re-Excision to Minimize Reoperation for Patients Undergoing Breast-Conserving Surgery. Ann Surg Oncol. 2020 Dec; 27 (13):5303-5311 Epub 2020 July 04
    View PubMed
  56. Eggermont AMM, Bellomo D, Arias-Mejias SM, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Murphree DH, Pittelkow MR, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, Rentroia-Pacheco B, Wever R, van Vliet MH, Dwarkasing J, Meves A. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model. Eur J Cancer. 2020 Nov; 140:11-18 Epub 2020 Oct 05
    View PubMed
  57. Yamashita TS, Pockaj BA, Bagaria SP, Flotte TJ, Fahy AS, de Azevedo RU, Harmsen WS, Block MS, Jakub JW. Clinical significance of SLN benign capsular nevi in patients with melanoma. J Surg Oncol. 2020 Nov; 122 (6):1043-1049 Epub 2020 July 22
    View PubMed
  58. Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, Jakub JW. Germline Genetic Mutations in a Multi-center Contemporary Cohort of 550 Phyllodes Tumors: An Opportunity for Expanded Multi-gene Panel Testing. Ann Surg Oncol. 2020 Oct; 27 (10):3633-3640 Epub 2020 June 05
    View PubMed
  59. Hallbeck MS, Law KE, Lowndes BR, Linden AR, Morrow M, Blocker RC, Cain SM, Degnim AC, Hieken TJ, Jakub JW, Racz JM, Farley DR, Nelson H, Boughey JC. Workload Differentiates Breast Surgical Procedures: NSM Associated with Higher Workload Demand than SSM. Ann Surg Oncol. 2020 May; 27 (5):1318-1326 Epub 2020 Jan 08
    View PubMed
  60. Contreras N, Jakub JW. The achilles heel of minimally invasive inguinal lymph node dissection: Seroma formation. Am J Surg. 2020 Apr; 219 (4):696-700 Epub 2019 June 24
    View PubMed
  61. Manrique OJ, Kapoor T, Banuelos J, Jacobson SR, Martinez-Jorge J, Nguyen MT, Tran NV, Harless CA, Degnim AC, Jakub JW. Single-Stage Direct-to-Implant Breast Reconstruction: A Comparison Between Subpectoral Versus Prepectoral Implant Placement. Ann Plast Surg. 2020 Apr; 84 (4):361-365
    View PubMed
  62. Banuelos J, Taslakian EN, Nguyen MT, Manrique OJ, Tran NV, Martinez-Jorge J, Hieken T, Jakub J, Habermann EB, Sharaf B. The American College of Surgeons National Quality Improvement Program Incompletely Captures Implant-Based Breast Reconstruction Complications. Ann Plast Surg. 2020 Mar; 84 (3):271-275
    View PubMed
  63. Manrique OJ, Huang TC, Martinez-Jorge J, Ciudad P, Forte AJ, Bustos SS, Boughey JC, Jakub JW, Degnim AC, Galan R. Prepectoral Two-Stage Implant-Based Breast Reconstruction with and without Acellular Dermal Matrix: Do We See a Difference? Plast Reconstr Surg. 2020 Feb; 145(2):263e-272e.
    View PubMed
  64. Vu TND, Melik RE, Nehring S, Bergquist W, Hoskin T, Day C, Jakub JW. Venous thromboembolism chemoprophylaxis in mastectomy patients: A 5-year follow-up study. J Surg Oncol. 2020 Feb; 121 (2):193-199 Epub 2019 Nov 22
    View PubMed
  65. Bellomo D, Arias-Mejias SM, Ramana C, Heim JB, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Pittelkow MR, DiCaudo DJ, Pockaj BA, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, van Vliet MH, Dwarkasing J, Meves A. Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. JCO Precis Oncol. 2020; 4:319-334 Epub 2020 Apr 14
    View PubMed
  66. Murphy BL, Woodwick AR, Murphy KM, Chandler KJ, Johnson GB, Hunt CH, Peller P, Jakub JW, Homb AC. (99m)Tc-Tilmanocept Versus (99m)Tc-Sulfur Colloid in Lymphoscintigraphy: Sentinel Lymph Node Identification and Patient-Reported Pain. J Nucl Med Technol. 2019 Dec; 47 (4):300-304 Epub 2019 Apr 24
    View PubMed
  67. Guru SD, Loprinzi CL, Yan E, Hoskin TL, Jakub JW. Contralateral Axillary Metastases in Breast Cancer: Stage IV Disease or a Locoregional Event? Am Surg. 2019 Dec 1; 85 (12):1391-1396
    View PubMed
  68. Banuelos J, Sabbagh MD, Roh SG, Nguyen MT, Lemaine V, Tran NV, Jacobson SR, Boughey JC, Jakub JW, Hieken TJ, Degnim AC, Mandrekar J, Berbari E, Sharaf B. Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years. Plast Reconstr Surg. 2019 Dec; 144 (6):1270-1277
    View PubMed
  69. Young WA, Degnim AC, Hoskin TL, Jakub JW, Nguyen MD, Tran NV, Harless CA, Manrique OJ, Boughey JC, Hieken TJ. Outcomes of > 1300 Nipple-Sparing Mastectomies with Immediate Reconstruction: The Impact of Expanding Indications on Complications. Ann Surg Oncol. 2019 Oct; 26 (10):3115-3123 Epub 2019 July 24
    View PubMed
  70. Murphy BL, Thiels CA, Hanson KT, McLaughlin S, Jakub JW, Gray RJ, Ubl DS, Habermann EB. Pain and opioid prescriptions vary by procedure after breast surgery. J Surg Oncol. 2019 Sep; 120 (4):593-602 Epub 2019 July 11
    View PubMed
  71. Manrique OJ, Charafeddine A, Abu-Ghname A, Banuelos J, Jacobson SR, Martinez-Jorge J, Nguyen MD, Harless C, Tran NV, Sharaf B, Jakub JW, Hieken TJ, Degnim AC, Boughey JC. Two-Staged Implant-Based Breast Reconstruction: A Long-Term Outcome Study in a Young Population. Medicina (Kaunas). 2019 Aug 14; 55 (8)
    View PubMed
  72. Al-Hilli Z, Choong G, Keeney MG, Visscher DW, Ingle JN, Goetz MP, Jakub JW. Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy. Breast Cancer Res Treat. 2019 Aug; 176 (3):709-716 Epub 2019 May 22
    View PubMed
  73. Sada A, Thiels CA, Britain MK, Dudakovic A, Bergquist WJ, Nickel SR, Moran MJ, Martinez-Jorge J, Jakub JW. Optimizing Discharge Opioid Prescribing Practices After Mastectomy With Immediate Reconstruction. Mayo Clin Proc Innov Qual Outcomes. 2019 Jun; 3 (2):183-188 Epub 2019 May 27
    View PubMed
  74. Manrique OJ, Banuelos J, Abu-Ghname A, Nguyen MD, Tran NV, Martinez-Jorge J, Harless C, Sharaf B, Jakub JW, Degnim AC, Boughey JC, Jacobson SR. Surgical Outcomes of Prepectoral Versus Subpectoral Implant-based Breast Reconstruction in Young Women. Plast Reconstr Surg Glob Open. 2019 Mar; 7 (3):e2119 Epub 2019 Mar 13
    View PubMed
  75. Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Goodellas C, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, I-SPY2 Investigators. Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2019; 5:2 Epub 2019 Jan 02
    View PubMed
  76. Racz JM, Block MS, Baum CL, Jakub JW. Management of local or regional non-nodal disease. J Surg Oncol. 2019 Jan; 119 (2):187-199 Epub 2018 Dec 12
    View PubMed
  77. Maus RLG, Jakub JW, Hieken TJ, Nevala WK, Christensen TA, Sutor SL, Flotte TJ, Markovic SN. Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma. Oncoimmunology. 2019; 8 (12):e1667742 Epub 2019 Sept 30
    View PubMed
  78. Veverka KK, Jakub JW, Baum CL. Responses to Topical Diphenylcyclopropenone as an Adjunct Treatment for In-Transit Melanoma: A Tertiary Referral Center Experience. Dermatol Surg. 2018 Dec; 44 (12):1501-1508
    View PubMed
  79. Gao RW, Park SS, Jakub JW, Hieken TJ, Conners AL, Neal L, Pruthi S, Corbin KS, Yan ES, Mutter RW, Stish BJ. Durable response of early-stage breast cancer to bilateral definitive SBRT in a medically inoperable patient. Pract Radiat Oncol. 2018 Nov - Dec; 8 (6):361-365 Epub 2018 Mar 18
    View PubMed
  80. Murphy BL, Ray-Zack MD, Reddy PN, Choudhry AJ, Zielinski MD, Habermann EB, Jakub LE Jr, Brandt KR, Jakub JW. Breast Cancer Litigation in the 21st Century. Ann Surg Oncol. 2018 Oct; 25 (10):2939-2947 Epub 2018 June 28
    View PubMed
  81. Nguyen TT, Hoskin TL, Day CN, Degnim AC, Jakub JW, Hieken TJ, Boughey JC. Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann Surg Oncol. 2018 Sep; 25 (9):2596-2602 Epub 2018 July 05
    View PubMed
  82. Gonzalez AB, Baum CL, Brewer JD, Arpey CJ, Harmsen WS, Suman VJ, Markovic SN, Jakub JW. Patterns of failure following the excision of in-transit lesions in melanoma and the influence of excisional margins. J Surg Oncol. 2018 Sep; 118 (4):606-613 Epub 2018 Aug 16
    View PubMed
  83. Jakub JW, Racz JM, Hieken TJ, Gonzalez AB, Kottschade LA, Markovic SN, Yan Y, Block MS. Neoadjuvant systemic therapy for regionally advanced melanoma. J Surg Oncol. 2018 May; 117 (6):1164-1169 Epub 2017 Dec 11
    View PubMed
  84. Murphy BL, Gonzalez AB, Keeney MG, Chen B, Conners AL, Henrichsen TL, Degnim AC, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Jakub JW. Ability of Intraoperative Pathologic Analysis of Ductal Carcinoma In Situ to Guide Selective Use of Sentinel Lymph Node Surgery. Am Surg. 2018 Apr 1; 84 (4):537-542
    View PubMed
  85. Sims JR, Grotz TE, Pockaj BA, Joseph RW, Foote RL, Otley CC, Weaver AL, Jakub JW, Price DL. Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patients. Surg Oncol. 2018 Mar; 27 (1):11-17 Epub 2017 Oct 26
    View PubMed
  86. Jakub JW, Peled AW, Gray RJ, Greenup RA, Kiluk JV, Sacchini V, McLaughlin SA, Tchou JC, Vierkant RA, Degnim AC, Willey S. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study. JAMA Surg. 2018 Feb 1; 153 (2):123-129
    View PubMed
  87. Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, and I-SPY 2 Investigators. Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2018; 4:26 Epub 2018 Aug 17
    View PubMed
  88. Murphy BL, Jakub JW. Response to HER2 status might be independent determinant associated with no residual disease at surgical resection in patients with DCIS. J Surg Oncol 2017 Nov; 116 (6):791 Epub 2017 June 19
    View PubMed
  89. Glorioso JM, Gonzalez Juarrero AB, Rodysill BR, Harmsen WS, Habermann EB, Carter JM, Mutter RW, Degnim AC, Jakub JW. Margin Proximity Correlates with Local Recurrence After Mastectomy for Patients Not Receiving Adjuvant Radiotherapy. Ann Surg Oncol. 2017 Oct; 24 (11):3148-3156 Epub 2017 July 05
    View PubMed
  90. Jakub JW, Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, Maimone S 4th, Keeney MG, McLaughlin SA, Pockaj BA, Chen B, Musonza T, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Shah HN, Degnim AC. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease. Ann Surg Oncol. 2017 Oct; 24 (10):2915-2924 Epub 2017 Aug 01
    View PubMed
  91. Zendejas B, Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Tyler D, Brady MS, Farley DR. Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedure. Surg Endosc. 2017 Aug; 31 (8):3313-3319 Epub 2016 Dec 07
    View PubMed
  92. Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, Keeney MG, Chen B, Nguyen TT, Harmsen WS, Habermann EB, Shah HN, Jakub JW. Identifying a subset of patients with DCIS who have a low likelihood of residual disease at surgical excision following a core needle biopsy. J Surg Oncol. 2017 Aug; 116 (2):213-219 Epub 2017 Apr 18
    View PubMed
  93. Pena A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, Jakub JW, Boughey JC, Visscher DW, Degnim AC. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast Cancer Res Treat. 2017 Jul; 164 (2):295-304 Epub 2017 May 04
    View PubMed
  94. Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Jakub JW, Krajewski AC, Jacobson SR, Hieken TJ. Outcomes and feasibility of nipple-sparing mastectomy for node-positive breast cancer Patients. Am J Surg. 2017 Apr; 213 (4):810-813 Epub 2016 Sept 03
    View PubMed
  95. Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Grotz TE, Allred JB, Suman VJ, Brady MS, Tyler D, Wayne JD, Nelson H. Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial. Ann Surg. 2017 Jan; 265 (1):192-196
    View PubMed
  96. Maus RLG, Jakub JW, Nevala WK, Christensen TA, Noble-Orcutt K, Sachs Z, Hieken TJ, Markovic SN. Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation. Front Immunol. 2017; 8:358 Epub 2017 Mar 29
    View PubMed
  97. Fahy AS, Grotz TE, Keeney GL, Glasgow AE, Habermann EB, Erickson L, Hieken TJ, Jakub JW. Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation. J Surg Oncol. 2016 Dec; 114: (7)879-883.
    View PubMed
  98. Stish BJ, Pafundi DH, Hieken TJ, Whitaker TJ, Furutani KM, Jakub JW, Boughey JC, Degnim AC, McLemore LB, Mou B, Mutter RW, Park SS. Feasibility and full-course dosimetry of an intraoperatively placed multichannel brachytherapy catheter for accelerated partial breast irradiation. Brachytherapy. 2016 Nov - Dec; 15 (6):796-803 Epub 2016 Sept 07
    View PubMed
  99. Murphy BL, Boughey JC, Degnim AC, Hieken TJ, Harmsen WS, Keeney GL, Jakub JW. A Picture is Worth a Thousand Words: Intraoperative Photography as a Quality Metric for Axillary Dissection. Ann Surg Oncol. 2016 Oct; 23 (11):3494-3500 Epub 2016 May 19
    View PubMed
  100. Hieken TJ, Mutter RW, Jakub JW, Boughey JC, Degnim AC, Sukov WR, Childs S, Corbin KS, Furutani KM, Whitaker TJ, Park SS. A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer. Ann Surg Oncol. 2016 Oct; 23 (10):3297-303 Epub 2016 June 22
    View PubMed
  101. Thiels CA, Gonzalez AB, Gray RJ, Jakub JW. Isolated limb perfusion in Merkel cell carcinoma offers high rate of complete response and durable local-regional control: Systematic review and institutional experience. J Surg Oncol. 2016 Aug; 114 (2):187-92 Epub 2016 May 18
    View PubMed
  102. Gonzalez AB, Jakub JW, Harmsen WS, Suman VJ, Markovic SN. Status of the Regional Nodal Basin Remains Highly Prognostic in Melanoma Patients with In-Transit Disease. J Am Coll Surg. 2016 Jul; 223 (1):77-85.e1 Epub 2016 Mar 26
    View PubMed
  103. Hoskin TL, Hieken TJ, Degnim AC, Jakub JW, Jacobson SR, Boughey JC. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. Surgery. 2016 Apr; 159 (4):1199-209 Epub 2015 Dec 17
    View PubMed
  104. White ML, Atwell TD, Kurup AN, Schmit GD, Carter RE, Geske JR, Kottschade LA, Pulido JS, Block MS, Jakub JW, Callstrom MR, Markovic SN. Recurrence and Survival Outcomes After Percutaneous Thermal Ablation of Oligometastatic Melanoma. Mayo Clin Proc. 2016 Mar; 91: (3)288-96.
    View PubMed
  105. Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS. Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. J Am Coll Surg. 2016 Mar; 222 (3):253-60 Epub 2015 Nov 25
    View PubMed
  106. Abdelsattar JM, Boughey JC, Fahy AS, Jakub JW, Farley DR, Hieken TJ, Degnim AC, Goede W, Mohan AT, Harmsen WS, Niesen AD, Tran NV, Bakri K, Jacobson SR, Lemaine V, Saint-Cyr M. Comparative Study of Liposomal Bupivacaine Versus Paravertebral Block for Pain Control Following Mastectomy with Immediate Tissue Expander Reconstruction. Ann Surg Oncol. 2016 Feb; 23 (2):465-70 Epub 2015 Aug 26
    View PubMed
  107. Al-Hilli Z, Thomsen KM, Habermann EB, Jakub JW, Boughey JC. Reoperation for Complications after Lumpectomy and Mastectomy for Breast Cancer from the 2012 National Surgical Quality Improvement Program (ACS-NSQIP). Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S459-69 Epub 2015 July 25
    View PubMed
  108. Grotz TE, Joseph RW, Pockaj BA, Foote RL, Otley CC, Bagaria SP, Weaver AL, Jakub JW. Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma is Associated with a Low Risk of Same-Nodal-Basin Recurrences. Ann Surg Oncol. 2015 Nov; 22 (12):4060-6 Epub 2015 Feb 13
    View PubMed
  109. Al-Hilli Z, Glazebrook KN, McLaughlin SA, Chan DM, Robinson KT, Giesbrandt JG, Slomka EL, Pizzitola VJ, Gray RJ, Jakub JW. Utilization of Multiple I-125 Radioactive Seeds in the Same Breast is Safe and Feasible: A Multi-institutional Experience. Ann Surg Oncol. 2015 Oct; 22: (10)3350-5.
    View PubMed
  110. Jakub JW, Grotz TE, Jordan P, Hunter E, Pittelkow M, Ramadass A, Akoulitchev A, Markovic S. A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma. Melanoma Res. 2015 Oct; 25: (5)406-11.
    View PubMed
  111. Jakub J, Gray R. Starting a Radioactive Seed Localization Program. Ann Surg Oncol. 2015 Oct; 22: (10)3197-202.
    View PubMed
  112. Krajewski AC, Boughey JC, Degnim AC, Jakub JW, Jacobson SR, Hoskin TL, Hieken TJ. Expanded Indications and Improved Outcomes for Nipple-Sparing Mastectomy Over Time. Ann Surg Oncol. 2015 Oct; 22 (10):3317-23 Epub 2015 July 23
    View PubMed
  113. Lemaine V, Hoskin TL, Farley DR, Grant CS, Boughey JC, Torstenson TA, Jacobson SR, Jakub JW, Degnim AC. Introducing the SKIN score: a validated scoring system to assess severity of mastectomy skin flap necrosis. Ann Surg Oncol. 2015 Sep; 22 (9):2925-32 Epub 2015 Jan 30
    View PubMed
  114. Grotz TE, Jakub JW, Mansfield AS, Goldenstein R, Enninga EA, Nevala WK, Leontovich AA, Markovic SN. Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma. Oncoimmunology. 2015 Aug; 4 (8):e1026504 Epub 2015 June 01
    View PubMed
  115. Kottschade LA, Grotz TE, Dronca RS, Salomao DR, Pulido JS, Wasif N, Jakub JW, Bagaria SP, Kumar R, Kaur JS, Morita SY, Moran SL, Nguyen JT, Nguyen EC, Hand JL, Erickson LA, Brewer JD, Baum CL, Miller RC, Swanson DL, Lowe V, Markovic SN. Rare presentations of primary melanoma and special populations: a systematic review. Am J Clin Oncol. 2014 Dec; 37 (6):635-41
    View PubMed
  116. Fahy AS, Jakub JW, Dy BM, Eldin NS, Harmsen S, Sviggum H, Boughey JC. Paravertebral blocks in patients undergoing mastectomy with or without immediate reconstruction provides improved pain control and decreased postoperative nausea and vomiting. Ann Surg Oncol. 2014 Oct; 21 (10):3284-9 Epub 2014 July 18
    View PubMed
  117. Degnim AC, Hoskin TL, Brahmbhatt RD, Warren-Peled A, Loprinzi M, Pavey ES, Boughey JC, Hieken TJ, Jacobson S, Lemaine V, Jakub JW, Irwin C, Foster RD, Sbitany H, Saint-Cyr M, Duralde E, Ramaker S, Chin R, Sieg M, Wildeman M, Scow JS, Patel R, Ballman K, Baddour LM, Esserman LJ. Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstruction. Ann Surg Oncol. 2014 Oct; 21 (10):3240-8 Epub 2014 Aug 06
    View PubMed
  118. Grotz TE, Kottschade L, Pavey ES, Markovic SN, Jakub JW. Adjuvant GM-CSF improves survival in high-risk stage iiic melanoma: a single-center Study. Am J Clin Oncol. 2014 Oct; 37 (5):467-72
    View PubMed
  119. Brown L, Harmsen W, Blanchard M, Goetz M, Jakub J, Mutter R, Petersen I, Rooney J, Stauder M, Yan E, Laack N. Once-daily radiation therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2014 Aug 1; 89 (5):997-1003 Epub 2014 Apr 07
    View PubMed
  120. Boughey JC, Hieken TJ, Jakub JW, Degnim AC, Grant CS, Farley DR, Thomsen KM, Osborn JB, Keeney GL, Habermann EB. Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: evaluation of the National Surgical Quality Improvement Program data. Surgery. 2014 Jul; 156 (1):190-7 Epub 2014 Mar 18
    View PubMed
  121. Grotz TE, Huebner M, Pockaj BA, Perkins S, Jakub JW. Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma. Ann Surg Oncol. 2013 Dec; 20(13):4370-7. Epub 2013 Sep 18.
    View PubMed
  122. Degnim AC, Scow JS, Hoskin TL, Miller JP, Loprinzi M, Boughey JC, Jakub JW, Throckmorton A, Patel R, Baddour LM. Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg. 2013 Aug; 258 (2):240-7
    View PubMed
  123. Grotz TE, Glorioso JM, Pockaj BA, Harmsen WS, Jakub JW. Preservation of the deep muscular fascia and locoregional control in melanoma. Surgery. 2013 Apr; 153: (4)535-41.
    View PubMed
  124. Tarantola TI, Vallow LA, Halyard MY, Weenig RH, Warschaw KE, Grotz TE, Jakub JW, Roenigk RK, Brewer JD, Weaver AL, Otley CC. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases. J Am Acad Dermatol. 2013 Mar; 68 (3):425-32 Epub 2012 Nov 27
    View PubMed
  125. Abbott AM, Grotz TE, Rueth NM, Hernandez Irizarry RC, Tuttle TM, Jakub JW. Minimally invasive inguinal lymph node dissection (MILND) for melanoma: experience from two academic centers. Ann Surg Oncol. 2013 Jan; 20(1):340-5. Epub 2012 Aug 9
    View PubMed
  126. Graham RP, Jakub JW, Brunette JJ, Reynolds C. Handling of radioactive seed localization breast specimens in the pathology laboratory. Am J Surg Pathol. 2012 Nov; 36: (11)1718-23.
    View PubMed
  127. Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, Deperi ER, Glazebrook KN. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol. 2012 Oct; 19(10):3131-8. Epub 2012 Jul 31.
    View PubMed
  128. Lovely JK, Nehring SA, Boughey JC, Degnim AC, Donthi R, Harmsen WS, Jakub JW. Balancing venous thromboembolism and hematoma after breast surgery. Ann Surg Oncol. 2012 Oct; 19 (10):3230-5 Epub 2012 July 21
    View PubMed
  129. Brahmbhatt RD, Huebner M, Scow JS, Harmsen WS, Boughey JC, Harris AM, Goede D, Jakub JW, Hieken TJ, Degnim AC. National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2012 Oct; 19 (10):3205-11 Epub 2012 July 06
    View PubMed
  130. Ansari B, Boughey JC, Adamczyk DL, Degnim AC, Jakub JW, Morton MJ. Should axillary ultrasound be used in patients with a preoperative diagnosis of ductal carcinoma in situ? Am J Surg. 2012 Sep; 204: (3)290-3.
    View PubMed
  131. Grotz TE, Tarantola TI, Otley CC, Weaver AL, McGree ME, Jakub JW. Natural history of merkel cell carcinoma following locoregional recurrence. Ann Surg Oncol. 2012 Aug; 19(8):2556-62. Epub 2012 Mar 28.
    View PubMed
  132. Erben Y, Ghosh K, Nassar A, Gimenez E, Jakub JW. Invasive lobular carcinoma of the nipple. Breast J. 2012 May-Jun; 18 (3):280-1 Epub 2012 Apr 05
    View PubMed
  133. Drackley NL, Degnim AC, Jakub JW, Cutshall SM, Thomley BS, Brodt JK, Vanderlei LK, Case JK, Bungum LD, Cha SS, Bauer BA, Boughey JC. Effect of massage therapy for postsurgical mastectomy recipients. Clin J Oncol Nurs. 2012 Apr; 16 (2):121-4
    View PubMed
  134. Miles RC, Gullerud RE, Lohse CM, Jakub JW, Degnim AC, Boughey JC. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age. Ann Surg Oncol. 2012 Apr; 19 (4):1153-9 Epub 2011 Oct 12
    View PubMed
  135. Diaz R, Degnim AC, Boughey JC, Nassar A, Jakub JW. A positive intramammary lymph node does not mandate a complete axillary node dissection. Am J Surg. 2012 Feb; 203(2):151-5. Epub 2011 Jul 23.
    View PubMed
  136. Grotz TE, Mansfield AS, Jakub JW, Markovic SN. Regional lymphatic immunity in melanoma. Melanoma Res. 2012 Feb; 22(1):9-18.
    View PubMed
  137. Grotz TE, Mansfield AS, Kottschade LA, Erickson LA, Otley CC, Markovic SN, Jakub JW. In-transit melanoma: an individualized approach. Oncology (Williston Park). 2011 Dec; 25(14):1340-8.
    View PubMed
  138. Reynolds C, Davidson JA, Lindor NM, Glazebrook KN, Jakub JW, Degnim AC, Sandhu NP, Walsh MF, Hartmann LC, Boughey JC. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved? Ann Surg Oncol. 2011 Oct; 18(11):3102-9. Epub 2011 Sep 27.
    View PubMed
  139. Ansari B, Morton MJ, Adamczyk DL, Jones KN, Brodt JK, Degnim AC, Jakub JW, Lohse CM, Boughey JC. Distance of breast cancer from the skin and nipple impacts axillary nodal metastases. Ann Surg Oncol. 2011 Oct; 18 (11):3174-80 Epub 2011 Aug 23
    View PubMed
  140. Osborn JB, Keeney GL, Jakub JW, Degnim AC, Boughey JC. Cost-effectiveness analysis of routine frozen-section analysis of breast margins compared with reoperation for positive margins. Ann Surg Oncol. 2011 Oct; 18(11):3204-9. Epub 2011 Aug 23.
    View PubMed
  141. Grotz TE, Markovic SN, Erickson LA, Harmsen WS, Huebner M, Farley DR, Pockaj BA, Donohue JH, Sim FH, Grant CS, Bagaria SP, Shives TC, Balch CM, Jakub JW, Mayo Clinic. Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma. Mayo Clin Proc. 2011 Jun; 86 (6):522-8
    View PubMed
  142. Mansfield AS, Holtan SG, Grotz TE, Allred JB, Jakub JW, Erickson LA, Markovic SN. Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Mod Pathol. 2011 Apr; 24 (4):487-94 Epub 2010 Dec 10
    View PubMed
  143. Thanarajasingam U, Chen B, Tortorelli CL, Jakub JW, Ghosh K. Diabetic mastopathy as a radiographically occult palpable breast mass. Case Rep Med. 2011; 2011:162350 Epub 2011 Nov 03
    View PubMed
  144. Jakub JW, Bryant K, Huebner M, Hoskin T, Boughey JC, Reynolds C, Degnim AC. The number of axillary lymph nodes involved with metastatic breast cancer does not affect outcome as long as all disease is confined to the sentinel lymph nodes. Ann Surg Oncol. 2011 Jan; 18(1):86-93. Epub 2010 Jul 01.
    View PubMed
  145. Mani A, Franco SX, Wang G, Abramson N, Schwartzberg LS, Jakub J, Tan-Chiu E, Schwartz MA, Frankel C, Krill-Jackson EA, Stein A, Perez AT, Vogel CL. A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer. Community Oncol. 2011; 8(5):209-15.
  146. Jakub JW, Boughey JC. Sentinel lymph node biopsy after chemotherapy. Current Breast Cancer Reports. 2011; 3(2):97-103.
  147. Fedko MG, Scow JS, Shah SS, Reynolds C, Degnim AC, Jakub JW, Boughey JC. Pure tubular carcinoma and axillary nodal metastases. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:338-42 Epub 2010 Sept 19
    View PubMed
  148. Pockaj BA, Wasif N, Dueck AC, Wigle DA, Boughey JC, Degnim AC, Gray RJ, McLaughlin SA, Northfelt DW, Sticca RP, Jakub JW, Perez EA. Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look? Ann Surg Oncol. 2010 Sep; 17 (9):2419-26 Epub 2010 Mar 16
    View PubMed
  149. Boughey JC, Donohue JH, Jakub JW, Lohse CM, Degnim AC. Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors. Cancer. 2010 Jul 15; 116 (14):3322-9
    View PubMed
  150. Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non palpable breast lesions. Am J Surg. 2010 Apr; 199 (4):522-8 Epub 2009 Dec 02
    View PubMed
  151. Scow JS, Reynolds CA, Degnim AC, Petersen IA, Jakub JW, Boughey JC. Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol. 2010 Apr 1; 101 (5):401-7
    View PubMed
  152. Grotz TE, Tortorelli CL, Degnim AC, Boughey JC, Whaley DH, Jakub JW. The use of radioactive seed localization for non-palpable non-breast lesions. Journal of Surgical Radiology. 2010; 1(2).
  153. Jakub JW, Russell G, Tillman CL, Lariscy C. Colon cancer and low lymph node count: who is to blame? Arch Surg. 2009 Dec; 144(12):1115-20.
    View PubMed
  154. Jakub JW, Huebner M, Shivers S, Nobo C, Puleo C, Harmsen WS, Reintgen DS. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node. Ann Surg Oncol. 2009 Aug; 16(8):2245-51. Epub 2009 Jun 11.
    View PubMed
  155. Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR, Melanoma Study. Metastatic malignant melanoma. G Ital Dermatol Venereol. 2009 Feb; 144(1):1-26.
    View PubMed
  156. McDermott DF, Sosman JA, Gonzalez R, Hodi FS, Linette GP, Richards J, Jakub JW, Beeram M, Tarantolo S, Agarwala S, Frenette G, Puzanov I, Cranmer L, Lewis K, Kirkwood J, White JM, Xia C, Patel K, Hersh E. Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group. J Clin Oncol. 2008 May 1; 26(13):2178-85.
    View PubMed
  157. Shivers S, Jakub J, Pendas S, Reintgen D. Molecular staging for patients with malignant melanoma. Expert Rev Anticancer Ther. 2007 Nov; 7(11):1665-74.
    View PubMed
  158. Jakub JW, Reintgen DS, Shivers S, Pendas S. Regional node dissection for melanoma: techniques and indication. Surg Oncol Clin N Am. 2007 Jan; 16(1):247-61.
    View PubMed
  159. Leong SP, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, Jakub J, Pendas S, Duhaime L, Cassell R, Gardner M, Giuliano R, Archie V, Calvin D, Mensha L, Shivers S, Cox C, Werner JA, Kitagawa Y, Kitajima M. Clinical patterns of metastasis. Cancer Metastasis Rev. 2006 Jun; 25(2):221-32.
    View PubMed
  160. Jakub JW, Garcia E, Giuliano R, Pendas S, Reintgen D. A black SLN in a melanoma patient. Contemp Surg. 2005; 61(8):403-5.
  161. Jakub JW, Ebert MD, Cantor A, Gardner M, Reintgen DS, Dupont EL, Cox CE, Shons AR. Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping. Plast Reconstr Surg. 2004 Dec; 114(7):1737-42.
    View PubMed
  162. Diaz NM, Cox CE, Ebert M, Clark JD, Vrcel V, Stowell N, Sharma A, Jakub JW, Cantor A, Centeno BA, Dupont E, Muro-Cacho C, Nicosia S. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol. 2004 Dec; 28(12):1641-5.
    View PubMed
  163. Shivers S, Alsarraj M, Guiliano R, Jakub J, Pendas S, Reintgen D. Molecular staging of melanoma. Ann Surg Oncol. 2004 Nov; 11(11):953-4.
    View PubMed
  164. Pendas S, Jakub J, Giuliano R, Gardner M, Swor GB, Reintgen DS. The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. Cancer Control. 2004 Jul-Aug; 11(4):231-5.
    View PubMed
  165. Jakub JW, Cox CE, Pippas AW, Gardner M, Pendas S, Reintgen DS. Controversial topics in breast lymphatic mapping. Semin Oncol. 2004 Jun; 31(3):324-32.
    View PubMed
  166. Pendas S, Giuliano R, Swor G, Gardner M, Jakub J, Reintgen DS. Worldwide experience with lymphatic mapping for invasive breast cancer. Semin Oncol. 2004 Jun; 31(3):318-23.
    View PubMed
  167. Reintgen D, Pendas S, Jakub J, Swor G, Giuliano R, Bauer J, Cassall R, Duhaime L, Alsarrai M, Shivers S. National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial. Semin Oncol. 2004 Jun; 31(3):363-73.
    View PubMed
  168. Cox CE, Furman B, Dupont EL, Jakub JW, Stowell N, Clark J, Ebert M. Novel techniques in sentinel lymph node mapping and localization of nonpalpable breast lesions: the Moffitt experience. Ann Surg Oncol. 2004 Mar; 11(3 Suppl):222S-6S.
    View PubMed
  169. Reintgen DS, Jakub JW, Pendas S, Swor G, Giuliano R, Shivers S. The staging of malignant melanoma and the Florida Melanoma Trial. Ann Surg Oncol. 2004 Mar; 11(3 Suppl):186S-91S.
    View PubMed
  170. Cox CE, White L, Stowell N, Clark J, Dickson D, Furman B, Weinberg E, Jakub J, Dupont E. Clinical considerations in breast cancer sentinel lymph node mapping: a Moffitt review. Breast Cancer. 2004; 11(3):225-32; discussion 264-6.
    View PubMed
  171. Jakub J, Pendas S, Swor G, Gardner M, Giuliano R, Reintgen D. "Ultrastaging" of breast cancer in the sentinel lymph node era. Clin Breast Cancer. 2004; 5(4):285-6.
  172. Jakub JW, Drake FD, Pippas AW, Gardner M, Fraile RJ, Giuliano R, Pendas S, Reintgen DS. A case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy. Cancer Control. 2003 Sep-Oct; 10(5):411-3.
    View PubMed
  173. Jakub JW, Ebert MD, Diaz NM, Cantor A, Reintgen DS, Dupont EL, Shons AR, Cox CE. Effect of lymphatic mapping on diagnosis and treatment of patients with T1a, T1b favorable breast cancer. Ann Surg. 2003 Jun; 237(6):838-41; discussion 841-3.
    View PubMed
  174. Jakub JW, Pendas S, Reintgen DS. Current status of sentinel lymph node mapping and biopsy: facts and controversies. Oncologist. 2003; 8(1):59-68.
    View PubMed
  175. Jakub JW, Diaz NM, Ebert MD, Cantor A, Reintgen DS, Dupont EL, Shons AR, Cox CE. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg. 2002 Oct; 184(4):302-6.
    View PubMed
  176. Gill SS, Jakub JW, Pease MC, Woollen CD. The economic impact of motor vehicle crashes: the cost of restrained versus unrestrained occupants in South Carolina. Am Surg. 2002 Jun; 68(6):569-74; discussion 574.
    View PubMed
  177. Cox CE, Jakub JW. Re: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg. 2002 May; 68(5):500-2.
    View PubMed
  178. Jakub JW, Cox CE. The Ghosh/Hartmann article reviewed: current status of prophylactic mastectomy. Oncology. 2002; 16(10):1319-32.
  179. Jakub JW, Jackson LD, Bynoe RP. Renal cell carcinoma identified after blunt abdominal trauma. Surg Rounds. 2000:612-6.
  180. Jakub JW, Zamora SM, Greene FL. Laparoscopic cholecystostomy. J S C Med Assoc. 1996 Jul; 92(7):302-5.
    View PubMed